Companies / Transphorm, Inc.
Transphorm, Inc.
TGANCIK 1715768
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | KKR Phorm Investors L.P. 10% owner | Sell Open-market sale | Common Stock | $124.50M | -24.4M -100.00% | 0 | high |
| Jul 21, 2023 | KKR Phorm Investors L.P. 10% owner | Buy Open-market buy | Common Stock | $5.73M | +1.7M +7.66% | 24,411,968 | high |
| Nov 5, 2021 | KKR Phorm Investors L.P. 10% owner | Buy Open-market buy | Common Stock | $5.00M | +1.0M +4.72% | 22,175,980 | high |
| Jun 1, 2022 | KKR Phorm Investors L.P. 10% owner | Exercise In-the-money exercise | Common Stock | $2.50M | +500K +2.25% | 22,675,980 | low |
| Jan 1, 2022 | Parikh Primit Executive | Other Withheld for taxes | Common Stock | $123.8K | -15K -5.86% | 248,485 | low |
| Jan 1, 2022 | Mishra Umesh Executive | Other Withheld for taxes | Common Stock | $123.8K | -15K -6.91% | 208,480 | low |
| Jan 1, 2022 | Rivas Mario CEO | Other Withheld for taxes | Common Stock | $94.8K | -12K -8.87% | 121,773 | low |
| Jan 1, 2023 | Mishra Umesh Executive | Other Withheld for taxes | Common Stock | $88.0K | -16K -7.53% | 198,784 | low |